Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for

Ben van Steenkiste1, Trudy van der Weijden, Henri E J H Stoffers

  • 1Department of General Practice, Centre for Quality of Care Research, Care and Public Health Research Institute (CAPHRI), the Netherlands. Ben.vanSteenkiste@hag.unimaas.nl

Insights

A 4-hour training on a cardiovascular risk decision tool did not improve general practitioner performance or patient risk perception. However, it did increase physical activity in men, suggesting potential for patient involvement strategies.

Area of Science:

  • Cardiology
  • Primary Care Medicine
  • Health Behavior Research

Background:

  • General practitioners (GPs) and patients exhibit suboptimal adherence to cardiovascular risk-reducing interventions.
  • GPs struggle to accurately assess cardiovascular risk due to multiple factors and find communicating this risk to patients challenging.

Purpose of the Study:

  • To enhance patient involvement in primary cardiovascular disease (CVD) prevention within primary care settings.
  • To evaluate the effectiveness of a decision support tool integrated with GP training.

Main Methods:

  • A cluster randomized trial involving 34 GPs and patients aged 40-75 without existing CVD.
  • Intervention group GPs received 4-hour training on cardiovascular risk guidelines and a decision support tool; control group received paper materials.
  • GPs' clinical performance, patient risk perception, and self-reported lifestyles were assessed at baseline and 6 months.

Main Results:

  • No significant improvement in GPs' clinical performance or patients' risk perception was observed after 6 months.
  • A statistically significant increase in self-reported physical activity was noted among men in the intervention group (OR 3.8, 95% CI 1.7-8.7).

Conclusions:

  • A 4-hour interactive training session did not ensure proper use of the decision support tool, failing to enhance GP performance or patient risk perception.
  • The observed positive impact on physical activity warrants further investigation into patient involvement strategies for cardiovascular risk reduction.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...